Type 2 Diabetes - Pipeline Review, H2 2017

  • ID: 4429850
  • Drug Pipelines
  • 1126 pages
  • Global Markets Direct
1 of 5

FEATURED COMPANIES

  • 4P Therapeutics LLC
  • Caelus Health
  • Genexine Inc
  • Leading BioSciences Inc
  • OPKO Health Inc
  • Sprint Bioscience AB
  • MORE
Type 2 Diabetes - Pipeline Review, H2 2017

Summary

The latest Pharmaceutical and Healthcare disease pipeline guide Type 2 Diabetes - Pipeline Review, H2 2017, provides an overview of the Type 2 Diabetes (Metabolic Disorders) pipeline landscape.

Type 2 diabetes is a chronic condition and is the most common form of diabetes. High levels of glucose are a characteristic feature. The body might become resistant to insulin or may not produce enough amounts. Due to abnormal insulin functioning, glucose is concentrated in the blood leading to elevated levels and hence causing type 2 diabetes. Symptoms include fatigue, weight issues, vision deficits and various other effects. Risk factors include family history, age, obesity, physical inactivity and high blood pressure. This condition is handled by lifestyle alterations and regular medications.

Report Highlights

The latest Pharmaceutical and Healthcare latest pipeline guide Type 2 Diabetes - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Type 2 Diabetes (Metabolic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Type 2 Diabetes (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Type 2 Diabetes and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 15, 2, 23, 66, 68, 3, 234, 77 and 8 respectively. Similarly, the Universities portfolio in Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages comprises 1, 1, 1, 68 and 20 molecules, respectively.

Type 2 Diabetes (Metabolic Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from our proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope:
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Type 2 Diabetes (Metabolic Disorders).
  • The pipeline guide reviews pipeline therapeutics for Type 2 Diabetes (Metabolic Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Type 2 Diabetes (Metabolic Disorders) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Type 2 Diabetes (Metabolic Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Type 2 Diabetes (Metabolic Disorders)
Reasons to Buy:
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Type 2 Diabetes (Metabolic Disorders).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Type 2 Diabetes (Metabolic Disorders) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • 4P Therapeutics LLC
  • Caelus Health
  • Genexine Inc
  • Leading BioSciences Inc
  • OPKO Health Inc
  • Sprint Bioscience AB
  • MORE
Introduction

Type 2 Diabetes - Overview

Type 2 Diabetes - Therapeutics Development

Type 2 Diabetes - Therapeutics Assessment

Type 2 Diabetes - Companies Involved in Therapeutics Development

Type 2 Diabetes - Drug Profiles

Type 2 Diabetes - Dormant Projects

Type 2 Diabetes - Discontinued Products

Type 2 Diabetes - Product Development Milestones

Appendix

List of Tables

Number of Products under Development for Type 2 Diabetes, H2 2017

Number of Products under Development by Companies, H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..1), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..2), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..3), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..4), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..5), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..6), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..7), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..8), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..9), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..10), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..11), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..12), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..13), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..14), H2 2017

Number of Products under Development by Universities/Institutes, H2 2017

Number of Products under Development by Universities/Institutes, H2 2017 (Contd..1), H2 2017

Number of Products under Development by Universities/Institutes, H2 2017 (Contd..2), H2 2017

Number of Products under Development by Universities/Institutes, H2 2017 (Contd..3), H2 2017

Products under Development by Companies, H2 2017

Products under Development by Companies, H2 2017 (Contd..1), H2 2017

Products under Development by Companies, H2 2017 (Contd..2), H2 2017

Products under Development by Companies, H2 2017 (Contd..3), H2 2017

Products under Development by Companies, H2 2017 (Contd..4), H2 2017

Products under Development by Companies, H2 2017 (Contd..5), H2 2017

Products under Development by Companies, H2 2017 (Contd..6), H2 2017

Products under Development by Companies, H2 2017 (Contd..7), H2 2017

Products under Development by Companies, H2 2017 (Contd..8), H2 2017

Products under Development by Companies, H2 2017 (Contd..9), H2 2017

Products under Development by Companies, H2 2017 (Contd..10), H2 2017

Products under Development by Companies, H2 2017 (Contd..11), H2 2017

Products under Development by Companies, H2 2017 (Contd..12), H2 2017

Products under Development by Companies, H2 2017 (Contd..13), H2 2017

Products under Development by Companies, H2 2017 (Contd..14), H2 2017

Products under Development by Companies, H2 2017 (Contd..15), H2 2017

Products under Development by Companies, H2 2017 (Contd..16), H2 2017

Products under Development by Companies, H2 2017 (Contd..17), H2 2017

Products under Development by Companies, H2 2017 (Contd..18), H2 2017

Products under Development by Companies, H2 2017 (Contd..19), H2 2017

Products under Development by Companies, H2 2017 (Contd..20), H2 2017

Products under Development by Companies, H2 2017 (Contd..21), H2 2017

Products under Development by Companies, H2 2017 (Contd..22), H2 2017

Products under Development by Companies, H2 2017 (Contd..23), H2 2017

Products under Development by Companies, H2 2017 (Contd..24), H2 2017

Products under Development by Companies, H2 2017 (Contd..25), H2 2017

Products under Development by Companies, H2 2017 (Contd..26), H2 2017

Products under Development by Universities/Institutes, H2 2017

Products under Development by Universities/Institutes, H2 2017 (Contd..1), H2 2017

Products under Development by Universities/Institutes, H2 2017 (Contd..2), H2 2017

Products under Development by Universities/Institutes, H2 2017 (Contd..3), H2 2017

Products under Development by Universities/Institutes, H2 2017 (Contd..4), H2 2017

Number of Products by Stage and Target, H2 2017

Number of Products by Stage and Target, H2 2017 (Contd..1), H2 2017

Number of Products by Stage and Target, H2 2017 (Contd..2), H2 2017

Number of Products by Stage and Target, H2 2017 (Contd..3), H2 2017

Number of Products by Stage and Target, H2 2017 (Contd..4), H2 2017

Number of Products by Stage and Target, H2 2017 (Contd..5), H2 2017

Number of Products by Stage and Target, H2 2017 (Contd..6), H2 2017

Number of Products by Stage and Target, H2 2017 (Contd..7), H2 2017

Number of Products by Stage and Mechanism of Action, H2 2017

Number of Products by Stage and Mechanism of Action, H2 2017 (Contd..1), H2 2017

Number of Products by Stage and Mechanism of Action, H2 2017 (Contd..2), H2 2017

Number of Products by Stage and Mechanism of Action, H2 2017 (Contd..3), H2 2017

Number of Products by Stage and Mechanism of Action, H2 2017 (Contd..4), H2 2017

Number of Products by Stage and Mechanism of Action, H2 2017 (Contd..5), H2 2017

Number of Products by Stage and Mechanism of Action, H2 2017 (Contd..6), H2 2017

Number of Products by Stage and Mechanism of Action, H2 2017 (Contd..7), H2 2017

Number of Products by Stage and Route of Administration, H2 2017

Number of Products by Stage and Molecule Type, H2 2017

Type 2 Diabetes - Pipeline by 4P Therapeutics LLC, H2 2017

Type 2 Diabetes - Pipeline by Addex Therapeutics Ltd, H2 2017

Type 2 Diabetes - Pipeline by Adocia SAS, H2 2017

Type 2 Diabetes - Pipeline by Aegis Therapeutics LLC, H2 2017

Type 2 Diabetes - Pipeline by AFFiRiS AG, H2 2017

Type 2 Diabetes - Pipeline by Allergan Plc, H2 2017

Type 2 Diabetes - Pipeline by Amarantus Bioscience Holdings Inc, H2 2017

Type 2 Diabetes - Pipeline by Amgen Inc, H2 2017

Type 2 Diabetes - Pipeline by AntriaBio Inc, H2 2017

Type 2 Diabetes - Pipeline by Aphios Corp, H2 2017

Type 2 Diabetes - Pipeline by Araim Pharmaceuticals Inc, H2 2017

Type 2 Diabetes - Pipeline by Arecor Ltd, H2 2017

Type 2 Diabetes - Pipeline by Arena Pharmaceuticals Inc, H2 2017

Type 2 Diabetes - Pipeline by Astellas Pharma Inc, H2 2017

Type 2 Diabetes - Pipeline by AstraZeneca Plc, H2 2017

Type 2 Diabetes - Pipeline by AusBio Ltd, H2 2017

Type 2 Diabetes - Pipeline by Avadel Pharmaceuticals Plc, H2 2017

Type 2 Diabetes - Pipeline by Bayer AG, H2 2017

Type 2 Diabetes - Pipeline by Betagenon AB, H2 2017

Type 2 Diabetes - Pipeline by Betta Pharmaceuticals Co Ltd, H2 2017

Type 2 Diabetes - Pipeline by Biocon Ltd, H2 2017

Type 2 Diabetes - Pipeline by BioLingus AG, H2 2017

Type 2 Diabetes - Pipeline by BioRestorative Therapies Inc, H2 2017

Type 2 Diabetes - Pipeline by Biozeus, H2 2017

Type 2 Diabetes - Pipeline by Biscayne Pharmaceuticals Inc, H2 2017

Type 2 Diabetes - Pipeline by Boehringer Ingelheim GmbH, H2 2017

Type 2 Diabetes - Pipeline by Boston Therapeutics Inc, H2 2017

Type 2 Diabetes - Pipeline by Braasch Biotech LLC, H2 2017

Type 2 Diabetes - Pipeline by Bristol-Myers Squibb Co, H2 2017

Type 2 Diabetes - Pipeline by C4X Discovery Holdings PLC, H2 2017

Type 2 Diabetes - Pipeline by Cadila Healthcare Ltd, H2 2017

Type 2 Diabetes - Pipeline by Cadila Pharmaceuticals Ltd, H2 2017

Type 2 Diabetes - Pipeline by Caelus Health, H2 2017

Type 2 Diabetes - Pipeline by Cardax Inc, H2 2017

Type 2 Diabetes - Pipeline by Carmot Therapeutics Inc, H2 2017

Type 2 Diabetes - Pipeline by Celon Pharma SA, H2 2017

Type 2 Diabetes - Pipeline by Center Laboratories Inc, H2 2017

Type 2 Diabetes - Pipeline by Chipscreen Biosciences Ltd, H2 2017

Type 2 Diabetes - Pipeline by Chong Kun Dang Pharmaceutical Corp, H2 2017

Type 2 Diabetes - Pipeline by CJ HealthCare Corp, H2 2017

Type 2 Diabetes - Pipeline by CohBar Inc, H2 2017

Type 2 Diabetes - Pipeline by Concenter BioPharma Silkim Ltd, H2 2017

Type 2 Diabetes - Pipeline by Connexios Life Sciences Pvt Ltd, H2 2017

Type 2 Diabetes - Pipeline by ConSynance Therapeutics Inc, H2 2017

Type 2 Diabetes - Pipeline by CSL Ltd, H2 2017

Type 2 Diabetes - Pipeline by CureDM Inc, H2 2017

Type 2 Diabetes - Pipeline by CymaBay Therapeutics Inc, H2 2017

Type 2 Diabetes - Pipeline by Daewoong Pharmaceutical Co Ltd, H2 2017

Type 2 Diabetes - Pipeline by Daiichi Sankyo Co Ltd, H2 2017

Type 2 Diabetes - Pipeline by Dance Biopharm Inc, H2 2017

Type 2 Diabetes - Pipeline by Delpor Inc, H2 2017

Type 2 Diabetes - Pipeline by Diabetology (Products) Ltd, H2 2017

Type 2 Diabetes - Pipeline by DiaMedica Therapeutics Inc, H2 2017

Type 2 Diabetes - Pipeline by Diamyd Medical AB, H2 2017

Type 2 Diabetes - Pipeline by Diasome Pharmaceuticals Inc, H2 2017

Type 2 Diabetes - Pipeline by DiscoveryBiomed Inc, H2 2017

Type 2 Diabetes - Pipeline by DNJ Pharma Inc, H2 2017

Type 2 Diabetes - Pipeline by Dong-A Socio Holdings Co Ltd, H2 2017

Type 2 Diabetes - Pipeline by Elcelyx Therapeutics Inc, H2 2017

Type 2 Diabetes - Pipeline by Eli Lilly and Co, H2 2017

Type 2 Diabetes - Pipeline by Energenesis Biomedical Co Ltd, H2 2017

Type 2 Diabetes - Pipeline by Enteris BioPharma Inc, H2 2017

Type 2 Diabetes - Pipeline by Enzene Biosciences Ltd, H2 2017

Type 2 Diabetes - Pipeline by Enzo Biochem Inc, H2 2017

Type 2 Diabetes - Pipeline by Epichem Pty Ltd, H2 2017

Type 2 Diabetes - Pipeline by Eternygen GmbH, H2 2017

Type 2 Diabetes - Pipeline by Evotec AG, H2 2017

Type 2 Diabetes - Pipeline by F. Hoffmann-La Roche Ltd, H2 2017

Type 2 Diabetes - Pipeline by Genexine Inc, H2 2017

Type 2 Diabetes - Pipeline by Genfit SA, H2 2017

Type 2 Diabetes - Pipeline by Genmedica Therapeutics SL, H2 2017

Type 2 Diabetes - Pipeline by Genovate Biotechnology Co LTD, H2 2017

Type 2 Diabetes - Pipeline by Geropharm LLC, H2 2017

Type 2 Diabetes - Pipeline by Gilead Sciences Inc, H2 2017

Type 2 Diabetes - Pipeline by GlaxoSmithKline Plc, H2 2017

Type 2 Diabetes - Pipeline by Glucox Biotech AB, H2 2017

Type 2 Diabetes - Pipeline by Hanmi Pharmaceuticals Co Ltd, H2 2017

Type 2 Diabetes - Pipeline by Heptares Therapeutics Ltd, H2 2017

Type 2 Diabetes - Pipeline by HitGen LTD, H2 2017

Type 2 Diabetes - Pipeline by Hyundai Pharmaceutical Co Ltd, H2 2017

Type 2 Diabetes - Pipeline by Immuron Ltd, H2 2017

Type 2 Diabetes - Pipeline by Inflazome Ltd, H2 2017

Type 2 Diabetes - Pipeline by Innovative Targeting Solutions Inc, H2 2017

Type 2 Diabetes - Pipeline by Inspyr Therapeutics Inc, H2 2017

Type 2 Diabetes - Pipeline by InStar Technologies AS, H2 2017

Type 2 Diabetes - Pipeline by Intarcia Therapeutics Inc, H2 2017

Type 2 Diabetes - Pipeline by Intas Pharmaceuticals Ltd, H2 2017

Type 2 Diabetes - Pipeline by Integral Molecular Inc, H2 2017

Type 2 Diabetes - Pipeline by Intercept Pharmaceuticals Inc, H2 2017

Type 2 Diabetes - Pipeline by Intrexon Corp, H2 2017

Type 2 Diabetes - Pipeline by Ionis Pharmaceuticals Inc, H2 2017

Type 2 Diabetes - Pipeline by Islet Sciences Inc, H2 2017

Type 2 Diabetes - Pipeline by Japan Tobacco Inc, H2 2017

Type 2 Diabetes - Pipeline by Jeil Pharmaceutical Co Ltd, H2 2017

Type 2 Diabetes - Pipeline by JHL Biotech Inc, H2 2017

Type 2 Diabetes - Pipeline by Jiangsu Hansoh Pharmaceutical Group Co Ltd, H2 2017

Type 2 Diabetes - Pipeline by Jiangsu Hengrui Medicine Co Ltd, H2 2017

Type 2 Diabetes - Pipeline by Johnson & Johnson, H2 2017

Type 2 Diabetes - Pipeline by Kadimastem Ltd, H2 2017

Type 2 Diabetes - Pipeline by Kadmon Corp LLC, H2 2017

Type 2 Diabetes - Pipeline by Kissei Pharmaceutical Co Ltd, H2 2017

Type 2 Diabetes - Pipeline by Kowa Co Ltd, H2 2017

Type 2 Diabetes - Pipeline by Lead Discovery Center GmbH, H2 2017

Type 2 Diabetes - Pipeline by Leading BioSciences Inc, H2 2017

Type 2 Diabetes - Pipeline by Lexicon Pharmaceuticals Inc, H2 2017

Type 2 Diabetes - Pipeline by LG Chem Ltd, H2 2017

Type 2 Diabetes - Pipeline by Ligand Pharmaceuticals Inc, H2 2017

Type 2 Diabetes - Pipeline by LipimetiX Development Inc, H2 2017

Type 2 Diabetes - Pipeline by Longevity Biotech Inc, H2 2017

Type 2 Diabetes - Pipeline by Luye Pharma Group Ltd, H2 2017

Type 2 Diabetes - Pipeline by Magnus Life Ltd, H2 2017

Type 2 Diabetes - Pipeline by MannKind Corp, H2 2017

Type 2 Diabetes - Pipeline by Medesis Pharma SA, H2 2017

Type 2 Diabetes - Pipeline by Medestea Research & Production SpA, H2 2017

Type 2 Diabetes - Pipeline by MedImmune LLC, H2 2017

Type 2 Diabetes - Pipeline by Medlab Clinical Ltd, H2 2017

Type 2 Diabetes - Pipeline by Melior Discovery Inc, H2 2017

Type 2 Diabetes - Pipeline by Mellitech SAS, H2 2017

Type 2 Diabetes - Pipeline by Merck & Co Inc, H2 2017

Type 2 Diabetes - Pipeline by Mesoblast Ltd, H2 2017

Type 2 Diabetes - Pipeline by Metabolic Solutions Development Company LLC, H2 2017

Type 2 Diabetes - Pipeline by Metabolys SAS, H2 2017

Type 2 Diabetes - Pipeline by Metacrine Inc, H2 2017

Type 2 Diabetes - Pipeline by Mitsubishi Chemical Holdings Corp, H2 2017

Type 2 Diabetes - Pipeline by Mitsubishi Tanabe Pharma Corp, H2 2017

Type 2 Diabetes - Pipeline by Naia Ltd, H2 2017

Type 2 Diabetes - Pipeline by Neurimmune Holding AG, H2 2017

Type 2 Diabetes - Pipeline by Neurocrine Biosciences Inc, H2 2017

Type 2 Diabetes - Pipeline by NGM Biopharmaceuticals Inc, H2 2017

Type 2 Diabetes - Pipeline by Nordic Bioscience A/S, H2 2017

Type 2 Diabetes - Pipeline by Novapeutics LLC, H2 2017

Type 2 Diabetes - Pipeline by Novartis AG, H2 2017

Type 2 Diabetes - Pipeline by NovaTarg Therapeutics Inc, H2 2017

Type 2 Diabetes - Pipeline by Novo Nordisk AS, H2 2017

Type 2 Diabetes - Pipeline by Omeros Corp, H2 2017

Type 2 Diabetes - Pipeline by OPKO Biologics Ltd, H2 2017

Type 2 Diabetes - Pipeline by OPKO Health Inc, H2 2017

Type 2 Diabetes - Pipeline by Oramed Pharmaceuticals Inc, H2 2017

Type 2 Diabetes - Pipeline by Paras Biopharmaceuticals Finland Oy, H2 2017

Type 2 Diabetes - Pipeline by Peptron Inc, H2 2017

Type 2 Diabetes - Pipeline by Pfizer Inc, H2 2017

Type 2 Diabetes - Pipeline by PharmaCyte Biotech Inc, H2 2017

Type 2 Diabetes - Pipeline by PharmaIN Corp, H2 2017

Type 2 Diabetes - Pipeline by Pila Pharma AB, H2 2017

Type 2 Diabetes - Pipeline by Poxel SA, H2 2017

Type 2 Diabetes - Pipeline by Prometheon Pharma LLC, H2 2017

Type 2 Diabetes - Pipeline by ProMetic Life Sciences Inc, H2 2017

Type 2 Diabetes - Pipeline by Prothena Corp Plc, H2 2017

Type 2 Diabetes - Pipeline by Purzer Pharmaceutical Co Ltd, H2 2017

Type 2 Diabetes - Pipeline by Reata Pharmaceuticals Inc, H2 2017

Type 2 Diabetes - Pipeline by ReCyte Therapeutics Inc, H2 2017

Type 2 Diabetes - Pipeline by reMYND NV, H2 2017

Type 2 Diabetes - Pipeline by Renova Therapeutics Inc, H2 2017

Type 2 Diabetes - Pipeline by Reset Therapeutics Inc, H2 2017

Type 2 Diabetes - Pipeline by Saniona AB, H2 2017

Type 2 Diabetes - Pipeline by Sanofi, H2 2017

Type 2 Diabetes - Pipeline by Sanwa Kagaku Kenkyusho Co Ltd, H2 2017

Type 2 Diabetes - Pipeline by SATT Conectus Alsace SAS, H2 2017

Type 2 Diabetes - Pipeline by SBI Pharmaceuticals Co Ltd, H2 2017

Type 2 Diabetes - Pipeline by Seres Therapeutics Inc, H2 2017

Type 2 Diabetes - Pipeline by Serodus ASA, H2 2017

Type 2 Diabetes - Pipeline by Serometrix LLC, H2 2017

Type 2 Diabetes - Pipeline by Sevion Therapeutics Inc, H2 2017

Type 2 Diabetes - Pipeline by Shenzhen HighTide Biopharmaceutical Ltd, H2 2017

Type 2 Diabetes - Pipeline by Shionogi & Co Ltd, H2 2017

Type 2 Diabetes - Pipeline by Sirona Biochem Corp, H2 2017

Type 2 Diabetes - Pipeline by SJT Molecular Research SL, H2 2017

Type 2 Diabetes - Pipeline by SK Chemicals Co Ltd, H2 2017

Type 2 Diabetes - Pipeline by Sprint Bioscience AB, H2 2017

Type 2 Diabetes - Pipeline by Sumitomo Dainippon Pharma Co Ltd, H2 2017

Type 2 Diabetes - Pipeline by Suzuken Co Ltd, H2 2017

Type 2 Diabetes - Pipeline by Taisho Pharmaceutical Holdings Co Ltd, H2 2017

Type 2 Diabetes - Pipeline by Takeda Pharmaceutical Co Ltd, H2 2017

Type 2 Diabetes - Pipeline by Tasly Pharmaceutical Group Co Ltd, H2 2017

Type 2 Diabetes - Pipeline by Teijin Pharma Ltd, H2 2017

Type 2 Diabetes - Pipeline by The Medicines Company, H2 2017

Type 2 Diabetes - Pipeline by Theracos Inc, H2 2017

Type 2 Diabetes - Pipeline by Thermalin Diabetes LLC, H2 2017

Type 2 Diabetes - Pipeline by Tiziana Life Sciences Plc, H2 2017

Type 2 Diabetes - Pipeline by Toray Industries Inc, H2 2017

Type 2 Diabetes - Pipeline by Torrent Pharmaceuticals Ltd, H2 2017

Type 2 Diabetes - Pipeline by Transgene Biotek Ltd, H2 2017

Type 2 Diabetes - Pipeline by TTY Biopharm Company Ltd, H2 2017

Type 2 Diabetes - Pipeline by Twoxar Inc, H2 2017

Type 2 Diabetes - Pipeline by Uni-Bio Science Group Ltd, H2 2017

Type 2 Diabetes - Pipeline by ViaCyte Inc, H2 2017

Type 2 Diabetes - Pipeline by Vichem Chemie Research Ltd, H2 2017

Type 2 Diabetes - Pipeline by Vicore Pharma AB, H2 2017

Type 2 Diabetes - Pipeline by Viking Therapeutics Inc, H2 2017

Type 2 Diabetes - Pipeline by Vivus Inc, H2 2017

Type 2 Diabetes - Pipeline by vTv Therapeutics Inc, H2 2017

Type 2 Diabetes - Pipeline by Vybion Inc, H2 2017

Type 2 Diabetes - Pipeline by XBiotech Inc, H2 2017

Type 2 Diabetes - Pipeline by XL-protein GmbH, H2 2017

Type 2 Diabetes - Pipeline by XOMA Corp, H2 2017

Type 2 Diabetes - Pipeline by XuanZhu Pharma Co Ltd, H2 2017

Type 2 Diabetes - Pipeline by Yabao Pharmaceutical Group Co Ltd, H2 2017

Type 2 Diabetes - Pipeline by Yuhan Corp, H2 2017

Type 2 Diabetes - Pipeline by Yungjin Pharm Co Ltd, H2 2017

Type 2 Diabetes - Pipeline by Zafgen Inc, H2 2017

Type 2 Diabetes - Pipeline by Zealand Pharma AS, H2 2017

Type 2 Diabetes - Dormant Projects, H2 2017

Type 2 Diabetes - Dormant Projects, H2 2017 (Contd..1), H2 2017

Type 2 Diabetes - Dormant Projects, H2 2017 (Contd..2), H2 2017

Type 2 Diabetes - Dormant Projects, H2 2017 (Contd..3), H2 2017

Type 2 Diabetes - Dormant Projects, H2 2017 (Contd..4), H2 2017

Type 2 Diabetes - Dormant Projects, H2 2017 (Contd..5), H2 2017

Type 2 Diabetes - Dormant Projects, H2 2017 (Contd..6), H2 2017

Type 2 Diabetes - Dormant Projects, H2 2017 (Contd..7), H2 2017

Type 2 Diabetes - Dormant Projects, H2 2017 (Contd..8), H2 2017

Type 2 Diabetes - Dormant Projects, H2 2017 (Contd..9), H2 2017

Type 2 Diabetes - Dormant Projects, H2 2017 (Contd..10), H2 2017

Type 2 Diabetes - Dormant Projects, H2 2017 (Contd..11), H2 2017

Type 2 Diabetes - Dormant Projects, H2 2017 (Contd..12), H2 2017

Type 2 Diabetes - Dormant Projects, H2 2017 (Contd..13), H2 2017

Type 2 Diabetes - Dormant Projects, H2 2017 (Contd..14), H2 2017

Type 2 Diabetes - Dormant Projects, H2 2017 (Contd..15), H2 2017

Type 2 Diabetes - Dormant Projects, H2 2017 (Contd..16), H2 2017

Type 2 Diabetes - Dormant Projects, H2 2017 (Contd..17), H2 2017

Type 2 Diabetes - Dormant Projects, H2 2017 (Contd..18), H2 2017

Type 2 Diabetes - Dormant Projects, H2 2017 (Contd..19), H2 2017

Type 2 Diabetes - Dormant Projects, H2 2017 (Contd..20), H2 2017

Type 2 Diabetes - Dormant Projects, H2 2017 (Contd..21), H2 2017

Type 2 Diabetes - Dormant Projects, H2 2017 (Contd..22), H2 2017

Type 2 Diabetes - Dormant Projects, H2 2017 (Contd..23), H2 2017

Type 2 Diabetes - Dormant Projects, H2 2017 (Contd..24), H2 2017

Type 2 Diabetes - Dormant Projects, H2 2017 (Contd..25), H2 2017

Type 2 Diabetes - Dormant Projects, H2 2017 (Contd..26), H2 2017

Type 2 Diabetes - Dormant Projects, H2 2017 (Contd..27), H2 2017

Type 2 Diabetes - Dormant Projects, H2 2017 (Contd..28), H2 2017

Type 2 Diabetes - Dormant Projects, H2 2017 (Contd..29), H2 2017

Type 2 Diabetes - Dormant Projects, H2 2017 (Contd..30), H2 2017

Type 2 Diabetes - Discontinued Products, H2 2017

Type 2 Diabetes - Discontinued Products, H2 2017 (Contd..1), H2 2017

Type 2 Diabetes - Discontinued Products, H2 2017 (Contd..2), H2 2017

Type 2 Diabetes - Discontinued Products, H2 2017 (Contd..3), H2 2017

Type 2 Diabetes - Discontinued Products, H2 2017 (Contd..4), H2 2017

Type 2 Diabetes - Discontinued Products, H2 2017 (Contd..5), H2 2017

Type 2 Diabetes - Discontinued Products, H2 2017 (Contd..6), H2 2017

Type 2 Diabetes - Discontinued Products, H2 2017 (Contd..7), H2 2017

Type 2 Diabetes - Discontinued Products, H2 2017 (Contd..8), H2 2017

Type 2 Diabetes - Discontinued Products, H2 2017 (Contd..9), H2 2017

List of Figures

Number of Products under Development for Type 2 Diabetes, H2 2017

Number of Products under Development by Companies, H2 2017

Number of Products under Development by Universities/Institutes, H2 2017

Number of Products by Top 10 Targets, H2 2017

Number of Products by Stage and Top 10 Targets, H2 2017

Number of Products by Top 10 Mechanism of Actions, H2 2017

Number of Products by Stage and Top 10 Mechanism of Actions, H2 2017

Number of Products by Top 10 Routes of Administration, H2 2017

Number of Products by Stage and Top 10 Routes of Administration, H2 2017

Number of Products by Top 10 Molecule Types, H2 2017

Number of Products by Stage and Top 10 Molecule Types, H2
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • 4P Therapeutics LLC
  • Addex Therapeutics Ltd
  • Adocia SAS
  • Aegis Therapeutics LLC
  • AFFiRiS AG
  • Allergan Plc
  • Amarantus Bioscience Holdings Inc
  • Amgen Inc
  • AntriaBio Inc
  • Aphios Corp
  • Araim Pharmaceuticals Inc
  • Arecor Ltd
  • Arena Pharmaceuticals Inc
  • Astellas Pharma Inc
  • AstraZeneca Plc
  • AusBio Ltd
  • Avadel Pharmaceuticals Plc
  • Bayer AG
  • Betagenon AB
  • Betta Pharmaceuticals Co Ltd
  • Biocon Ltd
  • BioLingus AG
  • BioRestorative Therapies Inc
  • Biozeus
  • Biscayne Pharmaceuticals Inc
  • Boehringer Ingelheim GmbH
  • Boston Therapeutics Inc
  • Braasch Biotech LLC
  • Bristol-Myers Squibb Co
  • C4X Discovery Holdings PLC
  • Cadila Healthcare Ltd
  • Cadila Pharmaceuticals Ltd
  • Caelus Health
  • Cardax Inc
  • Carmot Therapeutics Inc
  • Celon Pharma SA
  • Center Laboratories Inc
  • Chipscreen Biosciences Ltd
  • Chong Kun Dang Pharmaceutical Corp
  • CJ HealthCare Corp
  • CohBar Inc
  • Concenter BioPharma Silkim Ltd
  • Connexios Life Sciences Pvt Ltd
  • ConSynance Therapeutics Inc
  • CSL Ltd
  • CureDM Inc
  • CymaBay Therapeutics Inc
  • Daewoong Pharmaceutical Co Ltd
  • Daiichi Sankyo Co Ltd
  • Dance Biopharm Inc
  • Delpor Inc
  • Diabetology (Products) Ltd
  • DiaMedica Therapeutics Inc
  • Diamyd Medical AB
  • Diasome Pharmaceuticals Inc
  • DiscoveryBiomed Inc
  • DNJ Pharma Inc
  • Dong-A Socio Holdings Co Ltd
  • Elcelyx Therapeutics Inc
  • Eli Lilly and Co
  • Energenesis Biomedical Co Ltd
  • Enteris BioPharma Inc
  • Enzene Biosciences Ltd
  • Enzo Biochem Inc
  • Epichem Pty Ltd
  • Eternygen GmbH
  • Evotec AG
  • F. Hoffmann-La Roche Ltd
  • Genexine Inc
  • Genfit SA
  • Genmedica Therapeutics SL
  • Genovate Biotechnology Co LTD
  • Geropharm LLC
  • Gilead Sciences Inc
  • GlaxoSmithKline Plc
  • Glucox Biotech AB
  • Hanmi Pharmaceuticals Co Ltd
  • Heptares Therapeutics Ltd
  • HitGen LTD
  • Hyundai Pharmaceutical Co Ltd
  • Immuron Ltd
  • Inflazome Ltd
  • Innovative Targeting Solutions Inc
  • Inspyr Therapeutics Inc
  • InStar Technologies AS
  • Intarcia Therapeutics Inc
  • Intas Pharmaceuticals Ltd
  • Integral Molecular Inc
  • Intercept Pharmaceuticals Inc
  • Intrexon Corp
  • Ionis Pharmaceuticals Inc
  • Islet Sciences Inc
  • Japan Tobacco Inc
  • Jeil Pharmaceutical Co Ltd
  • JHL Biotech Inc
  • Jiangsu Hansoh Pharmaceutical Group Co Ltd
  • Jiangsu Hengrui Medicine Co Ltd
  • Johnson & Johnson
  • Kadimastem Ltd
  • Kadmon Corp LLC
  • Kissei Pharmaceutical Co Ltd
  • Kowa Co Ltd
  • Lead Discovery Center GmbH
  • Leading BioSciences Inc
  • Lexicon Pharmaceuticals Inc
  • LG Chem Ltd
  • Ligand Pharmaceuticals Inc
  • LipimetiX Development Inc
  • Longevity Biotech Inc
  • Luye Pharma Group Ltd
  • Magnus Life Ltd
  • MannKind Corp
  • Medesis Pharma SA
  • Medestea Research & Production SpA
  • MedImmune LLC
  • Medlab Clinical Ltd
  • Melior Discovery Inc
  • Mellitech SAS
  • Merck & Co Inc
  • Mesoblast Ltd
  • Metabolic Solutions Development Company LLC
  • Metabolys SAS
  • Metacrine Inc
  • Mitsubishi Chemical Holdings Corp
  • Mitsubishi Tanabe Pharma Corp
  • Naia Ltd
  • Neurimmune Holding AG
  • Neurocrine Biosciences Inc
  • NGM Biopharmaceuticals Inc
  • Nordic Bioscience A/S
  • Novapeutics LLC
  • Novartis AG
  • NovaTarg Therapeutics Inc
  • Novo Nordisk AS
  • Omeros Corp
  • OPKO Biologics Ltd
  • OPKO Health Inc
  • Oramed Pharmaceuticals Inc
  • Paras Biopharmaceuticals Finland Oy
  • Peptron Inc
  • Pfizer Inc
  • PharmaCyte Biotech Inc
  • PharmaIN Corp
  • Pila Pharma AB
  • Poxel SA
  • Prometheon Pharma LLC
  • ProMetic Life Sciences Inc
  • Prothena Corp Plc
  • Purzer Pharmaceutical Co Ltd
  • Reata Pharmaceuticals Inc
  • ReCyte Therapeutics Inc
  • reMYND NV
  • Renova Therapeutics Inc
  • Reset Therapeutics Inc
  • Saniona AB
  • Sanofi
  • Sanwa Kagaku Kenkyusho Co Ltd
  • SATT Conectus Alsace SAS
  • SBI Pharmaceuticals Co Ltd
  • Seres Therapeutics Inc
  • Serodus ASA
  • Serometrix LLC
  • Sevion Therapeutics Inc
  • Shenzhen HighTide Biopharmaceutical Ltd
  • Shionogi & Co Ltd
  • Sirona Biochem Corp
  • SJT Molecular Research SL
  • SK Chemicals Co Ltd
  • Sprint Bioscience AB
  • Sumitomo Dainippon Pharma Co Ltd
  • Suzuken Co Ltd
  • Taisho Pharmaceutical Holdings Co Ltd
  • Takeda Pharmaceutical Co Ltd
  • Tasly Pharmaceutical Group Co Ltd
  • Teijin Pharma Ltd
  • The Medicines Company
  • Theracos Inc
  • Thermalin Diabetes LLC
  • Tiziana Life Sciences Plc
  • Toray Industries Inc
  • Torrent Pharmaceuticals Ltd
  • Transgene Biotek Ltd
  • TTY Biopharm Company Ltd
  • Twoxar Inc
  • Uni-Bio Science Group Ltd
  • ViaCyte Inc
  • Vichem Chemie Research Ltd
  • Vicore Pharma AB
  • Viking Therapeutics Inc
  • Vivus Inc
  • vTv Therapeutics Inc
  • Vybion Inc
  • XBiotech Inc
  • XL-protein GmbH
  • XOMA Corp
  • XuanZhu Pharma Co Ltd
  • Yabao Pharmaceutical Group Co Ltd
  • Yuhan Corp
  • Yungjin Pharm Co Ltd
  • Zafgen Inc
  • Zealand Pharma AS
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll